Andrew Williamson - Profile and Investment Details

Investor Profile

Andrew Williamson is a Venture Capital, Investor, Private Equity Firm, Finance Operator based in Cambridge, England, United Kingdom with a diverse investment portfolio that includes companies such as Abcodia, Bicycle Therapeutics, AudioTelligence, Imagen Ltd, Secondmind, Jukedeck, Carrick Therapeutics, PolyProx, Sense Biodetection, PragmatIC Semiconductor, PredictImmune, Seldon, Undo, GeoSpock, Inivata, Z Factor, Storm Therapeutics, Microbiotica, Cytora, Congenica, Morphogen-IX, Origami Energy, Exvastat, Gyroscope Therapeutics, Swim.ai, CMR Surgical, Novomer, PervasID, Audio Analytic, Origami, Riverlane, CEDAR Audio, Fluidic Analytics, EnergyHub. Over time, Andrew Williamson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Andrew Williamson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Asset Management, Genetics, Databases, DeepTech, Medical Testing, Smart Cities, Banking, Artificial Intelligence (AI), Robotics, Information Technology (IT), Biotech, Analytics, Internet of Things (IoT), Mobile, Cloud Data Services, Finance, Medical Device, Bioinformatics, Software, Healthcare, Biotechnology, Computers, Open Source, Genomics, FinTech, Marine Technology, Audio, Logistics, Health Diagnostics, Medical, SaaS, Big Data, Therapeutics, Media and Entertainment, Machine Learning, Quantum Computing, Material Science may find it worthwhile to explore potential connections with Andrew Williamson, as their portfolio suggests a familiarity and interest in this area.

Understanding Andrew Williamson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.